172 related articles for article (PubMed ID: 16537495)
1. Genetic mosaics reveal both cell-autonomous and cell-nonautonomous function of murine p27Kip1.
Chien WM; Rabin S; Macias E; Miliani de Marval PL; Garrison K; Orthel J; Rodriguez-Puebla M; Fero ML
Proc Natl Acad Sci U S A; 2006 Mar; 103(11):4122-7. PubMed ID: 16537495
[TBL] [Abstract][Full Text] [Related]
2. Genetic characterization of p27(kip1) and stathmin in controlling cell proliferation in vivo.
Berton S; Pellizzari I; Fabris L; D'Andrea S; Segatto I; Canzonieri V; Marconi D; Schiappacassi M; Benevol S; Gattei V; Colombatti A; Belletti B; Baldassarre G
Cell Cycle; 2014; 13(19):3100-11. PubMed ID: 25486569
[TBL] [Abstract][Full Text] [Related]
3. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice.
Fero ML; Rivkin M; Tasch M; Porter P; Carow CE; Firpo E; Polyak K; Tsai LH; Broudy V; Perlmutter RM; Kaushansky K; Roberts JM
Cell; 1996 May; 85(5):733-44. PubMed ID: 8646781
[TBL] [Abstract][Full Text] [Related]
4. p27Kip1 repression of ErbB2-induced mammary tumor growth in transgenic mice involves Skp2 and Wnt/beta-catenin signaling.
Hulit J; Lee RJ; Li Z; Wang C; Katiyar S; Yang J; Quong AA; Wu K; Albanese C; Russell R; Di Vizio D; Koff A; Thummala S; Zhang H; Harrell J; Sun H; Muller WJ; Inghirami G; Lisanti MP; Pestell RG
Cancer Res; 2006 Sep; 66(17):8529-41. PubMed ID: 16951165
[TBL] [Abstract][Full Text] [Related]
5. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors.
Nakayama K; Ishida N; Shirane M; Inomata A; Inoue T; Shishido N; Horii I; Loh DY; Nakayama K
Cell; 1996 May; 85(5):707-20. PubMed ID: 8646779
[TBL] [Abstract][Full Text] [Related]
6. p27(Kip1) is required to maintain proliferative quiescence in the adult cochlea and pituitary.
Oesterle EC; Chien WM; Campbell S; Nellimarla P; Fero ML
Cell Cycle; 2011 Apr; 10(8):1237-48. PubMed ID: 21403466
[TBL] [Abstract][Full Text] [Related]
7. Cooperation between cyclin E and p27(Kip1) in pituitary tumorigenesis.
Roussel-Gervais A; Bilodeau S; Vallette S; Berthelet F; Lacroix A; Figarella-Branger D; Brue T; Drouin J
Mol Endocrinol; 2010 Sep; 24(9):1835-45. PubMed ID: 20660298
[TBL] [Abstract][Full Text] [Related]
8. Differential gene expression of p27Kip1 and Rb knockout pituitary tumors associated with altered growth and angiogenesis.
Chien WM; Garrison K; Caufield E; Orthel J; Dill J; Fero ML
Cell Cycle; 2007 Mar; 6(6):750-7. PubMed ID: 17361101
[TBL] [Abstract][Full Text] [Related]
9. Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1).
MartÃn A; Odajima J; Hunt SL; Dubus P; Ortega S; Malumbres M; Barbacid M
Cancer Cell; 2005 Jun; 7(6):591-8. PubMed ID: 15950907
[TBL] [Abstract][Full Text] [Related]
10. HMGA2 cooperates with either p27
Fedele M; Paciello O; De Biase D; Monaco M; Chiappetta G; Vitiello M; Barbieri A; Rea D; Luciano A; Papparella S; Arra C; Fusco A
Cell Cycle; 2018; 17(5):580-588. PubMed ID: 29157111
[TBL] [Abstract][Full Text] [Related]
11. Mutation and expression analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in pituitary tumors.
Takeuchi S; Koeffler HP; Hinton DR; Miyoshi I; Melmed S; Shimon I
J Endocrinol; 1998 May; 157(2):337-41. PubMed ID: 9659297
[TBL] [Abstract][Full Text] [Related]
12. p27Kip1-deficient mice exhibit accelerated growth hormone-releasing hormone (GHRH)-induced somatotrope proliferation and adenoma formation.
Teixeira LT; Kiyokawa H; Peng XD; Christov KT; Frohman LA; Kineman RD
Oncogene; 2000 Apr; 19(15):1875-84. PubMed ID: 10773877
[TBL] [Abstract][Full Text] [Related]
13. Mutation and expression analysis of the p27/kip1 gene in corticotrophin-secreting tumours.
Dahia PL; Aguiar RC; Honegger J; Fahlbush R; Jordan S; Lowe DG; Lu X; Clayton RN; Besser GM; Grossman AB
Oncogene; 1998 Jan; 16(1):69-76. PubMed ID: 9467944
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional activation of the mixed lineage leukemia-p27Kip1 pathway by a somatostatin analogue.
Horiguchi K; Yamada M; Satoh T; Hashimoto K; Hirato J; Tosaka M; Yamada S; Mori M
Clin Cancer Res; 2009 Apr; 15(8):2620-9. PubMed ID: 19318494
[TBL] [Abstract][Full Text] [Related]
15. p27(Kip1), a double-edged sword in Shh-mediated medulloblastoma: Tumor accelerator and suppressor.
Bhatia B; Malik A; Fernandez-L A; Kenney AM
Cell Cycle; 2010 Nov; 9(21):4307-14. PubMed ID: 21051932
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of p27Kip1 expression is required for development and function of T cells.
Tsukiyama T; Ishida N; Shirane M; Minamishima YA; Hatakeyama S; Kitagawa M; Nakayama K; Nakayama K
J Immunol; 2001 Jan; 166(1):304-12. PubMed ID: 11123306
[TBL] [Abstract][Full Text] [Related]
17. Altered expression of cell cycle proteins and prolonged duration of cardiac myocyte hyperplasia in p27KIP1 knockout mice.
Poolman RA; Li JM; Durand B; Brooks G
Circ Res; 1999 Jul; 85(2):117-27. PubMed ID: 10417393
[TBL] [Abstract][Full Text] [Related]
18. A morphogenetic wave of p27Kip1 transcription directs cell cycle exit during organ of Corti development.
Lee YS; Liu F; Segil N
Development; 2006 Aug; 133(15):2817-26. PubMed ID: 16790479
[TBL] [Abstract][Full Text] [Related]
19. Cdc2-cyclin E complexes regulate the G1/S phase transition.
Aleem E; Kiyokawa H; Kaldis P
Nat Cell Biol; 2005 Aug; 7(8):831-6. PubMed ID: 16007079
[TBL] [Abstract][Full Text] [Related]
20. p27(Kip1) deficiency promotes prostate carcinogenesis but does not affect the efficacy of retinoids in suppressing the neoplastic process.
Taylor W; Mathias A; Ali A; Ke H; Stoynev N; Shilkaitis A; Green A; Kiyokawa H; Christov K
BMC Cancer; 2010 Oct; 10():541. PubMed ID: 20932324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
